McKesson

Medicines to millions, outcomes to all

Irving, TX, US

McKesson is an American publicly traded pharmaceutical and healthcare company, the 9th largest by revenue in the United States and the largest healthcare company in the nation by delivering one-third of all pharmaceutical products used in North America.

Shareable draft

Check out McKesson on @MedStartr Today McKesson is an American publicly traded pharmaceutical and healthcare company, the 9th largest by revenue in the United States and the largest healthcare company in the nation by delivering one-third of all pharmaceutical products used in North America. #BiopharmaceuticalServices #MentalBehavioralHealth #Ophthalmology #Retina #CancerOncology #HealthcareInfrastructure #MedMo #MedStartrVentures

https://www.medstartr.ai/s/jq3k5Yy5KxA

Note, this image was autogenerated by Syggy based on what we know about the company. It is not an official company publication.

Get Involved in McKesson

How We Help

Core Technology

Pharmacy automation, data analytics, healthcare information technology services, and investments in AI and automation, including collaboration with Microsoft utilizing Azure AI for oncology documents.

Key Differentiators

Extensive logistics and distribution network (next-day delivery to 95% of customers with 99.8% order accuracy), significant market share (distributes a third of all pharmaceutical products in North America), technological innovation, strategic focus on high-growth segments (oncology and biopharma services), and commitment to health equity by improving access to medications and healthcare services for underserved populations.

Clinical Focus

Specialty care, particularly oncology and biopharmaceutical services, including solutions for community-based oncology practices and multispecialty providers in retina and ophthalmology.

Target Customers

Retail pharmacies, hospitals, physician offices, government entities, and pharmaceutical companies.

Product Stage

Mature

Company Info

Business Model: B2B
Founded: 1828
Website: www.mckesson.com

Disease Areas

Biopharmaceutical Services Mental Health Ophthalmology Retina Cancer & Oncology

Technologies

Analytics & BIPharmacy AutomationHealthcare Information TechnologyAutomationAI & Machine Learning

Clinical & IP

🔬

Clinical Validation

Real-world evidence from iKnowMed EHR system supported first FDA approval for metastatic Merkel Cell Carcinoma drug. Exclusive specialty pharmacy partner for SKYCLARYS (omaveloxolone), FDA-approved Feb 28, 2023 for Friedreich ataxia. 25+ years oncology/rare disease expertise.

🌐Website

MedStartr Engagement Score

The MedStartr Index is a reflection of how the crowds that come to MedStartr everyday to find healthcare innovations reacted. Calculated by our AI agent Fyggy based on algorithms we have been building since 2012 and over 100 different factors, the math is proprietary and complex. Suffice to say, it has been found to be highly correlative with early stage company growth. What you see here is the public version. To learn more or to get deeper access to our predictive data on startup success for your fund or company, click here.

Comments

Comments from new members are shown once the company's team has approved them. Please follow the community rules.

Be the first to comment.

What do you think of McKesson?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Submit anonymously — my name won't be shown to the team or on this profile

Your scores and comments are shown with your review on this company's profile.